MyOme helps identify genes that cause disease and act based on leading science. Your data is secure, portable and usable throughout life. We are currently keeping a low profile but always interested to hear from smart, passionate people with a background in bio stats, data science, and ML. You must be willing to work with other very talented people!
Location: United States, California, Palo Alto
Employees: 11-50
Total raised: $23M
Founded date: 2017
Investors 4
| Date | Name | Website |
| - | Foresite C... | foresiteca... |
| - | HOF Capita... | hofcapital... |
| 30.08.2022 | MBC BioLab... | mbcbiolabs... |
| 26.02.2021 | HOF Capita... | hofvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.06.2022 | Series B | $23M | Foresite C... |
Mentions in press and media 5
| Date | Title | Description |
| 25.02.2026 | Free genetic testing program aims to improve medical care across Alabama | An initiative aimed at improving medical care and addressing chronic disease is now underway in Alabama. Catalyst, a precision medicine program led by the Alabama nonprofit Southern Research in collaboration with Broad Clinical Labs at the ... |
| 22.06.2022 | As the crypto winter sets in, some VCs are taking the long view | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Good morning. Kevin Kelleher here, filling in for Jessica who is on vacation this week. Paid Cont... |
| 21.06.2022 | MyOme Raises $23M in Series B Funding | MyOme, a Menlo Park, CA-based clinical whole genome platform analysis company, raised $23m in Series B financing. The round, which brought the total raised to over $36M, was led by Healthcare Venture Partners. The company intends to use the... |
| 21.06.2022 | MyOme Raises $23M Series B Financing Round | MENLO PARK, CA, MyOme, a clinical whole genome platform analysis company, has raised $23 million in an oversubscribed series B financing round. >> Click here for more funding data on MyOme >> To export MyOme funding data to ... |
| - | Можно ли выбрать здорового ребенка: стартап Genomic Prediction ищет рак и диабет у эмбрионов Статьи редакции | Тесты стоят тысячи долларов, но учёные сомневаются в их эффективности. 19 19 комментариев 770 просмотров Sheba" data-image-src="https://leonardo.osnova.io/e9f12f98-547e-5b76-9f97-7417e4306d09/"> Sheba В 2020 году родился п... |